Movement Alert|Synopsys Rises 3.13% in Pre-Market Trading, Elliott Representative Officially Joins Board as Multiple Firms Raise Target Prices

Market Focus
06/01

On June 1, Synopsys rose 3.13% in pre-market trading, trading at $490.5/share, with trading volume of approximately $2.75 million.

On the news front, activist investor Elliott Investment Management's representative Jesse Cohn officially joined Synopsys' board of directors on June 1, expanding the board to 11 members. Under the cooperation agreement, Elliott has committed to customary standstill provisions, pledging not to increase its stake beyond 4.9% or maintain economic exposure exceeding 7.5%. Additionally, following the company's Q2 earnings release showing revenue of $22.76 billion (up 42% YoY) and adjusted EPS of $3.35 beating consensus of $3.15, multiple institutions raised their target prices — Citi lifted its target to $610 maintaining a Buy rating, while Rosenblatt raised to $575 also maintaining Buy. HSBC also adjusted its target from $460 to $490.

After a post-earnings pullback from approximately $527 to around $490, the formal board appointment catalyzing governance optimization expectations, combined with broad institutional bullish consensus, drove the pre-market rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10